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Understanding information ﬂow in sensory pathways requires cell-selective approaches to
manipulate the activity of deﬁned neurones. Primary afferent nociceptors, which detect painful
stimuli,areenrichedinspeciﬁcvoltage-gatedsodiumchannel(VGSC)subtypes.Toxinsderived
from venomous animals can be used to dissect the contributions of particular ion currents to
cellphysiology.Herewehaveusedatransgenicapproachtotargetamembrane-tetheredisoform
of the conotoxin MrVIa (t-MrVIa) only to nociceptive neurones in mice. T-MrVIa transgenic
mice show a 44±7% reduction of tetrodotoxin-resistant (TTX-R) VGSC current densities.
This inhibition is permanent, reversible and does not result in functional upregulation of
TTX-sensitive (TTX-S) VGSCs, voltage-gated calcium channels (VGCCs) or transient receptor
potential (TRP) channels present in nociceptive neurones. As a consequence of the reduction
ofTTX-RVGSCcurrents,t-MrVIatransgenicmicedisplaydecreasedinﬂammatorymechanical
hypersensitivity, cold pain insensitivity and reduced ﬁring of cutaneous C-ﬁbres sensitive to
noxious cold temperatures. These data validate the use of genetically encoded t-toxins as a
powerfultooltomanipulateVGSCsinspeciﬁccelltypeswithinthemammaliannervoussystem.
Thisnovel geneticmethodology canbeusedforcircuitmappingandhasthekeyadvantagethat
it enables the dissection of the contribution of speciﬁc ionic currents to neuronal function and
to behaviour.
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Introduction
Neuronal communication relies on action potentials
(APs) generated by the activity of voltage-gated sodium
channels (VGSCs) following membrane depolarisation.
The alkaloid toxin tetrodotoxin (TTX) has been
exploited for more than 40years due to its unique
ability to block VGSCs and therefore to assess the
contribution of these channels to cell excitability and AP
propagation. Nociceptive sensory neurones (nociceptors)
detect noxious peripheral stimuli; this information is
then transmitted to the superﬁcial dorsal horn of the
spinal cord, relayed to the brain, and perceived as pain
(Lewin & Moshourab, 2004). Nociceptors express two
unusual VGSCs, Nav1.8 and Nav1.9, which are resistant
to TTX (Dib-Hajj et al. 1998; Akopian et al. 1999). Nav1.8
generatessodiumcurrentswithahighactivationthreshold
(−40mV) and slow inactivation (Sangameswaran et al.
1997; Akopian et al. 1999; Renganathan et al. 2002),
whereas Nav1.9 produces a persistent current with a
more hyperpolarised voltage dependence and ultraslow
recovery from inactivation (Baker, 2005; Cummins et al.
2007). In addition nociceptors are enriched in the Nav1.7
TTX-SVGSCsubtype(Nassaretal.2004)whichproduces
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the threshold currents (Matsutomi et al. 2006). Small
molecules that speciﬁcally block the function of these
VGSC subtypes include chemical tools (Jarvis et al.
2007), small interfering RNAs (Dong et al. 2007), and
venom-derived toxins (Terlau & Olivera, 2004). The
μO-conotoxins MrVIa and MrVIb were the ﬁrst group
of peptide toxins reported to inhibit VGSC currents in
mammalian dorsal root ganglia (DRG) neurones (Daly
et al. 2004). MrVIa was found to inhibit TTX-R VGSC
currents with an IC50 value of ∼80nM and a ∼10 times
higher IC50 value (∼1μM) for TTX-S sodium currents
(Daly et al. 2004; see Supplemental material associated
with the current paper, Table1, available online only).
In this study we have used the tethered toxin
approach (Iba˜ nez-Tallon et al. 2004; Holford et al. 2009)
combined with cell-speciﬁc transgenesis, to deliver a
genetically encoded tethered form of the neurotoxin
MrVIa to nociceptors in mice. We show that this
approach can be successfully used to manipulate VGSC
currents in a cell-autonomous manner. Furthermore, the
nociceptor-speciﬁc inhibition of VGSC currents in these
transgenic mice leads to speciﬁc changes in the ﬁring
of noxious cold-sensitive nociceptors and reduction in
inﬂammation-induced pain behaviour.
Methods
Mice were housed in the animal facility of the
Max-Delbr¨ uck Center with ad libitum access to food
and water in an air-conditioned room at 22–23◦C with
a standard 12h light/dark cycle. Mice were killed by
placementinaCO2-ﬁlledchamberfora2–4minfollowed
by cervical dislocation. All procedures conformed to the
German guidelines of animal experimentation laid down
by the government. Animal housing and care, as well as
protocolsforkillingmice,areregisteredwithandapproved
bytheappropriateGermanfederalauthorities(Landesamt
f¨ urGesundheitundSoziales),whichalsogovernedproper
implementation.
Generation of Tg-t-MrVIa bacterial artiﬁcial
chromosome (BAC) transgenic mice
The mouse BAC clone (RP23-214H2) encompassing
the Scn10a gene (Invitrogen) was modiﬁed to include
the t-MrVIa expression cassette using the two-step
recombination system (Gong et al. 2002). After electro-
porationandhomologousrecombination,resolvedclones
were screened by PCR and Southern blotting. The
modiﬁed BAC for injection was puriﬁed by CsCl,
linearised and 3ngμl−1 of BAC DNA was injected into
fertilised oocytes of hybrid BDF mice.
Southern blot analyses
Genomic DNA (5μg) from each transgenic founder
line was digested with NcoI and separated by gel
electrophoresis. After gel denaturation (0.5 M NaOH,
1.5 MNaCl)andequilibration(10×saline–sodiumcitrate
buffer (SSC)), membrane blotting (Hybond N+ from
Amersham) was performed in 10×SSC. The membrane
was quickly washed in 2×SSC, dried for 2h and
crosslinked with UV light (Hoefer). DNA probes
were radioactively labelled with α-32P-dCTP (NEN)
using the Prime-It RmT Random Primer Labeling
kit (Stratagene). Twenty-ﬁve nanograms of the probe
was puriﬁed via Probe-Quant G50 micro-columns
(Amersham) and denatured at 95◦C for 5min before
hybridisation.Hybridisationwasperformedat65◦Co v er -
night in 5×Denhardt’s solution, 6×S S C ,0 . 5 %S D Sa n d
100μgml −1 salmon sperm DNA. The membrane was
washedin2×SSC/0.1%SDSfollowedbystringentwashes
in 0.1×SSC/0.1% SDS. Autoradiograms were exposed at
−70◦C for 3days.
Reverse Transcription PCR (RT-PCR)
Mouse tissues were rapidly dissected, collected in
Trizol and homogenised. Total RNA was extracted
by phenol/chloroform and treated with DNaseI
(Invitrogen). RT-PCRs were performed using one-step
platinum RT-PCR (Invitrogen). Primer pairs used were:
t-MrVIa-F: 5 -TGGGAGTACTGCATAGTGCCGAT-3 ,
t-MrVIa-R: 5 -CCCGTAGTTCCATCCTTCCTTCAA-3 ;
Nav1.8-F: 5 -TAACGTGTGGGTCTCTGTGC-3 ,
Nav1.8-R: 5 -AGGTATGGAGCCAGGTCCTC-3 ;
β-actin-F: 5 -TCGTGCGTGACATCAAAGAGAAGC-3 ,
β-actin-R: 5 -ATGGATGCCACAGGATTCCATACC-3 .
In situ hybridisation
RNA probes were synthesised with T7 RNA polymerase
usingDIGlabelling(Roche)andpuriﬁedwiththeRNeasy
kit (Qiagen). Dorsal root ganglia (DRG) from neonatal
mice were collected in ice-cold PBS and frozen in OCT
(Sakura). Cryosections were cut with 12μm thickness.
In situ hybridisation was performed with DIG-labelled
probes as described (Muller et al. 2005).
Patch-clamp electrophysiology and data analysis
Whole-cell patch-clamp recordings were performed on
DRG cultures from P7–P15 mice as previously described
(Hu & Lewin, 2006) and 100ngml−1 nerve growth factor
was added to the culture medium. Recordings were done
4–24h after plating, using borosilicate capillaries with a
resistance of 5–8M . For VGSC recordings, cells were
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perfused with extracellular solution containing (in mM):
140 NaCl, 4 KCl, 1 MgCl2,2C a C l 2, 4 glucose, 10 Hepes
(pH7.4) and pipettes were ﬁlled with solution containing
(in mM): 122 KCl, 10 NaCl, 1 MgCl2, 1 EGTA, 10 Hepes
(pH7.3). PI-PLC (Prozyme) was applied with 10μgml −1
for 1h at 37◦C. TTX experiments were performed with
0.5μM TTX. Membrane potentials were kept at −60mV,
prepulsed to −120mV for 150ms and depolarised from
−50 to +40mV for 50ms in increments of 10mV. For
current clamp analyses, neurones were held at resting
membrane potential and current injection was increased
from 80pA in 80pA increments. For VGCC recordings,
the bath solution was replaced with (mM): 140 TEA-Cl,
2C a C l 2,1 0H e p e s ,1 0g l u c o s ea n d1 0 0n M TTX, pH7.4
with TEA-OH. The pipette solution contained (mM): 120
CsCl, 4 MgCl2,1 0H e p e s ,1 0E G T A ,p H7 . 3w i t hC s O H .
Currents were activated by 100ms depolarisation pulses
from a holding potential of −80 to 0mV with 10s inter-
vals.RecordingswereperformedusinganEPC10ampliﬁer
(HEKA)atasamplingrateof50kHz.Theseriesresistance
was compensated for 40–60%. Data acquisition and
analysis were performed with Patchmaster and Fitmaster
software (HEKA Electronics, Darmstadt, Germany).
Skin–nerve assays
Single afferent units of the saphenous nerve from
adult mice were identiﬁed using a mechanical stimulus
(Milenkovic et al. 2008). C-ﬁbres were subsequently
examined for responsiveness to a cold ramp in which the
temperature decreased from 30 to 0◦C. Experiments were
carried out blind, i.e. the genotypes of the mice were not
known to the experimenter. Cold stimuli were delivered
with a computer-controlled Peltier device in contact with
the skin receptive ﬁeld.
Electroporation and immunostaining of DRG cultures
DRG neurones were isolated from an adult mouse and
cultured as previously described (Hu & Lewin, 2006).
Two hundred micrograms per millilitre of biotinylated
isolectin-B4 (IB4; Vector Labs) were used for IB4
live-stainings. DRGs were electroporated (Amaxa) with
5μgo ft h ep C S 2 + eukaryotic expression plasmid
containing t-MrVIA (CS2-t-MrVIA) and 0.5μgo f
pCS2+ plasmid encoding the green ﬂuorescent protein
(CS2-EGFP) and plated on poly-L-lysine–laminin-coated
coverslips. One day later, cells were ﬁxed with 4%
paraformaldehyde (PFA) and washed in PBS. Three per
centgoatserumwasusedforblocking.Thefollowinganti-
bodies and markerswere used: mouseanti-FLAG (Sigma)
at 1:1000, wheat germ agglutinin (Molecular Probes) at
1:200 (5μgml −1), goat anti-mouse-Alexa633(Molecular
Probes) at 1:400. Pictures were taken on a Zeiss LSM
confocal microscope.
Transfection and immunoprecipitation
in HEK293-T cells
HEK293-T cells were transfected with the CS2-t-MrVIa
expression vector using lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Immuno-
precipitation with FLAG agarose beads (Sigma) and
Western blot assays were performed as described
(Iba˜ nez-Tallon et al. 2002).
Immunostaining of spinal cord sections
Mice (n=1 per genotype) were anaesthetized by intra-
peritoneal injection of 500μl of 5mg Ketavet/200μg
Rompun in saline. Reﬂex responses such as limb
withdrawal to paw pressure were used to indicate the
need for a further dose of anaesthetic. Mice were then
perfused with 4% PFA and cryosections were cut with
14μm thickness. Mouse sections were blocked with 3%
goat serum in PBS. The following antibodies and marker
were used for immunostaining: rabbit anti-subP (Zymed
Laboratories) at 1:1000, isolectin-B4–Alexa488 (Vector
Labs)at1:500andhorseanti-rabbit–Alexa594(Molecular
Probes) at 1:1000.
Calcium imaging
Standard fura-2-based ratiometric calcium imaging was
usedtorecordresponsesofDRGneuronescultivatedfrom
either wild-type or Tg-t-MrVIa mice (2–5weeks of age)
toapplicationofdifferentTRPchannelagonists:capsaicin
(TRPV1, 100nM, 30s), menthol (TRPM8, 100mM,3 0s )
andcinnamaldehyde(TRPA1,100mM,30s).KCl(40mM,
10s) was applied at the end of experiments and only
cells exhibiting a robust response were analysed. An
inverted microscope (Zeiss Observer A1) equipped with
a MetaFluor photonics imaging system, including Poly-
chromator V, and a CoolSNAP ES camera (Visitron) was
used for cell imaging. Mouse genotype was unknown to
the experimenter.
Frog surgery and oocyte recordings
Xenopus laevis female frogs (n=5) were anaesthetized
by immersion for 30min in a 0.35% tricaine (Roth,
Karlsruhe, Germany) solution until the animals were
completely immobile and no further reﬂex limb
withdrawal was detected. Frogs were rinsed in water
before surgery and kept on ice during the surgery
procedure. A relatively small piece of ovary was taken
after performing a 1–2cm-long abdominal incision
through the overlying skin and a second incision through
the muscles. The muscular incision was closed with
DS16-5USP re-absorbable sterile surgical thread (Catgut
GmbH). The skin incision was closed with DS16-5USP
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non-absorbable sterile surgical thread (Catgut GmbH)
and removed at the next surgery. After surgery frogs
were kept for one day of observation in the laboratory
before being returned to the main aquarium. The
preparation of Xenopus laevis oocytes, cRNA trans-
cripts and two-electrode voltage clamp recordings were
conducted as described previously (Iba˜ nez-Tallon et al.
2002).VGSCsubunitcRNAsaloneorwithtetheredtoxins
(ratio channel:toxin was 1:4) were injected into oocytes
and recorded 3–5days later.
Electron microscopy
Mice (n=2 per genotype) were anaesthetized
by intra-peritoneal injection of 500μlo f5 m g
Ketavet/200μg Rompun in saline. Reﬂex responses
such as limb withdrawal to paw pressure were used
to indicate the need for a further dose of anaesthetic.
Saphenous nerves were isolated from mice which had
been perfused with 4% paraformaldehyde and postﬁxed
in 4% paraformaldehyde/2.5% glutaraldehyde in PBS.
Following treatment with 1% OsO4 in 0.1 M phosphate
buffer for 2h for osmication, tissue samples were
dehydrated in a graded ethanol series and propylene
oxide and embedded in Poly/BedR 812 (Polysciences,
Inc., Eppelheim, Germany). Semi-thin sections (1μm)
were stained with toluidine blue. Ultra-thin sections
(70nm) were contrasted with uranyl acetate and lead
citrate. The numbers of non-myelinated and myelinated
axons in the saphenous nerve of wild-type and transgenic
mice were determined by the counting of 12 random
ﬁelds under the electron microscope and normalising
to total cross-sectional nerve area observed in semi-thin
sections.
Behavioural experiments
Mice were backcrossed to C57/BL6/J for at least ﬁve
generations. Motor coordination: motor coordination was
assessed by placing the mice on an accelerating rotarod
apparatus (Ugo Basile, Italy). Animals were scored for
time to fall. Thermal nociception: thermal latency was
determinedusingthePlantartest(UgoBasile)(Hargreaves
et al. 1988). Fifteen minutes after placing the mice in the
Plexiglaschamberahighintensitylightbeamwasdirected
at the plantar surface of the hindpaw. Movement of the
paw stopped the light beam and the latency was indicated
on a digital screen. Measurements were made ﬁve times
on each paw and mean values were used for statistical
analysis. Mechanical nociception: mechanical sensitivity
was determined using a dynamic plantar aesthesiometer
(Ugo Basile, Milan, Italy). All animals were acclimatised
to the behavioural testing apparatus for 15min. An
increasing mechanical force (1gs−1) was applied to the
plantar surface of the mouse hindpaw. Each paw was
measured ﬁve times and mean values of the applied
forces were determined and used for statistical analysis.
Cold nociception: mice were placed onto a Peltier-cooled
plate maintained at 0±1◦C. The number of lickings and
jumpings were determined during 90s. Preferential heat
test:m i c eh a df r e ea c c e s st ot w op l a t e sk e p ta t1 0 ◦C
and 30◦C. The time spent on each plate was measured.
Inﬂammatory pain:m i c e( n=10 per genotype) were
anaesthetized by isoﬂurane inhalation. Thirty microlitres
of 2% carrageenan in saline (Fluka) was injected into the
plantar surface of the mouse right hindpaw to induce
inﬂammatory hyperalgesia. On the following 3days mice
were tested for responses to heat and mechanical stimuli
asdescribedfortheacutepainstudies.Micewerekilledby
placing in a box ﬁlled with 100% CO2 at the termination
of the tests.
Statistical analysis
Results are presented as means± S.E.M. Unpaired t tests
or two-way ANOVAs were used when indicated. P <0.05
was considered statistically signiﬁcant.
Results
To generate a membrane-tethered isoform of MrVIa
(t-MrVIa)weinsertedanucleotidesequencecodingforthe
maturetoxinbetweenthesequencescodingforasecretion
signalandaglycophosphatidylinositol(GPI)anchorsignal
(Iba˜ nez-Tallon et al. 2004) (Fig.1A). Tethered toxin
expression in nociceptors was achieved by (BAC) trans-
genic methodology (Gong et al. 2002) using genomic
DNA that contains the Scn10a nociceptor-speciﬁc gene
encodingfortheNav1.8VGSCα-subunit.Figure1Bshows
the diagram of the BAC containing the Scn10a gene
and the homology boxes for recombination with the
modiﬁed shuttle vector containing the t-toxin cassette.
Four transgenic founderlines were identiﬁed by Southern
blotting(Fig.1C).ComparisonoftheendogenousScn10a
allele to the transgene band indicated that transgenic
lines 2 and 27 had the highest BAC transgene copy
number. We encountered breeding problems with trans-
genic line 27 in that very few transgenic mice were born,
which may have been a non-speciﬁc effect due to the
size or the site of transgene insertion. We thus used
line2 (Tg(Scn10a-t-MrVIa)2Iit referred to hereafter as
Tg-t-MrVIa mice) for all further experiments.
Tg-t-MrVIamiceexpresst-MrVIaandScn10ainDRGs,
but not in other tissues along the nociceptive pathway
whereas wild-type littermates showed comparable levels
of Scn10a transcripts in DRGs, but lacked t-MrVIa
expression (Fig.2A). As expected from the developmental
pattern of Scn10a (Benn et al. 2001), in situ hybridisation
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indicated that t-MrVIa transcripts were present during
embryonicdevelopment(Fig.2B).Inadultmice,t-MrVIa
transcripts were detected in small-diameter nociceptors,
but not in large-diameter sensory neurones (Fig.2C).
An important feature of membrane t-toxins is their
cell-autonomous action. To assess, whether this property
was maintained in vivo, we prepared DRG primary
cultures, which contain a mixture of sensory neurone
typese.g.nociceptorsandmechanoreceptors.Nociceptors
werediscriminatedfrommechanoreceptorsbymeasuring
AP conﬁguration using the whole-cell patch clamp
technique (Fig.2L; AP half-peak width >3.1ms for
nociceptorsand<0.8msformechanoreceptors;seeonline
Supplemental Table2) and cell soma size (<25μms o m a
diameter for nociceptors and >25μm for mechano-
receptors; Supplemental Table2) as previously described
(Stucky & Lewin, 1999; Lawson, 2002). Representative
traces of VGSC currents, evoked by step depolarisation
in voltage clamp mode, in nociceptors and mechano-
receptors of both Tg-t-MrVIa mice and wild-type
littermates are shown in Fig.2D and G. Current–voltage
relations indicated a signiﬁcant reduction of VGSC
currents in nociceptors of Tg-t-MrVIa mice compared
to wild-type littermates (Fig.2E). In contrast, VGSC
currents in mechanoreceptors of Tg-t-MrVIa mice were
indistinguishable from those measured in mechano-
receptors of wild-type (Wt) littermates (Fig.2G and H).
Normalisation of peak VGSC currents to cell capacitance
indicated a 41.1±9% reduction of peak current
densities in nociceptors of Tg-t-MrVIa mice compared
to controls (Wt: 413.7±37.2pApF−1, Tg-t-MrVIa:
243.5±37.2pApF−1, n=32, P <0.05). However, no
difference was observed in mechanoreceptors (Wt:
306.9±57.4pApF−1,Tg-t-MrVIa:332.8±26.8pApF−1,
n=9) (Fig.2I; Supplemental Table2). To exclude the
possibility that the t-MrVIa toxin could be affecting
other ion channels present in nociceptors besides VGSCs,
we tested the functionality of VGCC (Fig.2J and
K) and TRP channels (Fig.1 in online Supplemental
material). Patch-clamp recordings of VGCCs performed
by step depolarisations indicated no differences between
nociceptors of Tg-t-MrVIa mice compared to wild-type
littermates (Fig.2J). Current–voltage relationships did
not differ between nociceptors of Tg-t-MrVIa and
wild-type mice with currents measured with increasing
voltage steps from −50 to +40mV, and maximal peak
currents obtained at a voltage depolarisation from
−50 to −10mV (Wt: −1.11±0.9nA, Tg-t-MrVIa:
−1.13±0.8nA,n=10each)(Fig.2K).Thefunctionality
and incidence of the TRP channels: TRPV1, TRPM8
and TRPA1 was measured by fura-2-based imaging
of increases in [Ca2+]i in DRG neurones through
the sequential application of the speciﬁc activators
capsaicin, menthol and cinnamaldehyde (Supplemental
Fig.1A and C). No signiﬁcant differences in the
percentage of DRG neurones responding to each agonist
were observed between Tg-t-MrVIa mice compared
to wild-type littermates (capsaicin: Wt 35.8±8.1%,
Tg-t-MrVIa 35.5±5.1; menthol: Wt 15.3±5.6%,
Figure 1. Generation of BAC transgenic mice encoding
membrane-tethered MrVIa toxin
A, diagram showing t-MrVIa (green ribbon) including a FLAG epitope
for immunodetection, a ﬂexible poly (asparagine-glycine) linker (grey)
and a GPI tether to the cell membrane. B, schematic overview of the
BAC modiﬁcation by two-step homologous recombination. The
modiﬁed shuttle vector (SV) contains the t-toxin cassette (green),
ﬂanked by a secretion signal (sec) and a polyA (pA), inserted between
two recombination boxes (A and B in red) corresponding to the
sequences ﬂanking the initiator methionine of the Scn10a gene
encoding the Nav1.8 VGSC subunit. Recombination (red lines) with
the Scn10a BAC results in the modiﬁed BAC and the free shuttle
vector. Scn10a gene promoter (black arrow), Scn10a exons (grey
boxes), selection markers (dark green boxes), NcoI restriction sites for
Southern blot (N), PI-SceI restriction site for BAC linearisation (P). C,
Southern blot of transgenic founder lines. Lines 2 and 27 showed the
highest relative ratio of the transgene band (∼2.3 kb) in comparison
with the endogenous Scn10a allele (∼1.5 kb) indicative of high BAC
copy number.
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Figure 2. Cell-autonomous inhibition of sodium currents in nociceptors of Tg-t-MrVIa mice
A, co-expression of Scn10a and t-MrVIa transcripts in DRGs of Tg-t-MrVIa mice detected by RT-PCR analysis (Sk,
skin; Bs, brain stem; Co, cortex. B, in situ hybridisation on spinal cord sections of mouse embryos (E15) show
strong t-MrVIa signal in DRGs but not in spinal cord (Sc) of Tg-t-MrVIa mice. Vc, vertebral column. Scale bar:
100 μm. C, t-MrVIa transcripts were detected by in situ hybridisation in nociceptors (arrows) but not mechano-
receptors (arrowheads) of Tg-t-MrVIa mice (2–4 weeks old). Scale bar: 50 μm. D–H, voltage-gated currents were
evoked by step depolarisations from −50 mV to +40 mV preceded by a hyperpolarizing prepulse from −60 to
−120 mV to prevent inactivation. D and E, representative traces and current–voltage relationships of inward
currents indicate a signiﬁcant reduction of sodium currents in nociceptors of Tg-t-MrVIa mice in comparison to
wild-type littermates. F, current–voltage relations of outward currents are not affected in nociceptors of Tg-t-MrVIa
mice. G and H, representative traces and current–voltage relations of inward currents, evoked by the same protocol
shown in D, indicate no differences in mechanoreceptors of Tg-t-MrVIa mice and wild-type littermates. I, peak
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Tg-t-MrVIa13.8±4.0;cinnamaldehyde:Wt10.1±6.6%,
Tg-t-MrVIa 11.6±6.2, n=4 for both genotypes)
(Supplemental Fig.1B and D). These results show that
these ion channels are not non-speciﬁcally affected by
genetic expression of the t-toxin in these neurones. Other
parameters, such as voltage-gated potassium outward
currents(Fig.2F)andtherestingmembranepotential(Wt
−51.9.±1.95mV, Tg-t-MrVIa −52.7±1.1mV, n=32;
Supplemental Table2), were also unaltered in nociceptors
of Tg-t-MrVIa mice compared to controls. These results
indicate that t-MrVIa is cell autonomous and speciﬁc for
VGSCs in vivo.
Nociceptors, electroporated with t-MrVIa and
EGFP, showed FLAG immunolabelling at the cell
membrane, which was abolished after treatment with
phosphatidylinositol-speciﬁc phospholipaseC (PI-PLC)
that cleaves GPI-anchored proteins from the cell surface
(Fig.3A). Immunoprecipitation assays indicated that
t-MrVIaisenrichedinmembranefractionsandcannotbe
detected in the culture medium (Fig.3B). VGSC currents
were measured before and after treatment with PI-PLC.
Total peak current densities in nociceptors of Tg-t-MrVIa
micewererestoredto87.5±8.6%ofcontrolcurrentsafter
PI-PLC (Fig.3C). Taken together, these data demonstrate
that t-MrVIa acts at the cell surface to block VGSCs.
A number of studies have reported that native MrVIa
and its close relative MrVIb preferentially block TTX-R
VGSCs, but at higher concentrations a subset of TTX-S
channelsare also affected by these toxins (Daly et al. 2004;
onlineSupplementalTable1).InSupplementalTable1we
havepresentedanoverviewofthereportedVGSCblocking
capabilities of the native soluble forms of μO-conotoxins
MrVIa and MrVIb in different experimental systems.
These studies show that while the native conotoxins
MrVIa/b are not highly selective for only one type of
VGSC, they can discriminate between TTX-R channels
present in nociceptors over TTX-S. Although the relative
extent of the inhibition of VGSC current depends on
the assay, and there is no direct comparison of all
α-subunits within one experimental set of data, it
would seem that native MrVIa/b preferentially blocks
Nav1.8 followed by Nav1.7, Nav1.4 and Nav1.2. To
determine whether the modiﬁed MrVIa used in this
study maintains the characteristics of the native soluble
MrVIa form, we performed oocyte electrophysiological
assays with t-MrVIa and different VGSC α-subunits.
VGSC current densities are signiﬁcantly reduced in nociceptors of Tg-t-MrVIa mice (243.5 ± 37.2 pA pF−1)w i t h
respect to wild-type mice (413.7 ± 37.2 pA pF−1)( n = 32 per group) and unchanged in mechanoreceptors (n = 9
per group). P < 0.05 two-way ANOVA in E and H; P > 0.05 two-way ANOVA in F; P < 0.05 t test in I. J and
K, representative traces (J) and current–voltage relations (K) of voltage-gated calcium currents, evoked by step
depolarisations from −90 mV to +40 mV, indicate no differences in nociceptors of Tg-t-MrVIa mice and wild-type
littermates (n = 10 per group). L, representative action potentials used to identify nociceptors and mechano-
receptors.
These experiments show signiﬁcant block of Nav1.2, but
not of Nav1.1, Nav1.3 and Nav1.6 VGSCs by t-MrVIa
(Supplemental Fig.2) in agreement with the reported
afﬁnitiesofthesolubletoxin(SupplementalTable1).Thus
ourexperimentalevidencesuggeststhatthetetherdoesnot
change the speciﬁcity of the MrVIa toxin.
We next used TTX to discriminate between TTX-R
and TTX-S currents present in nociceptors. TTX-R
currents in nociceptors of t-MrVIa transgenic mice
show a 44±7% reduction compared to wild-type
mice (Wt: 284.3±34.1pApF−1, n=30; Tg-t-MrVIa:
158.6±20.4pApF−1, n=31, P <0.5). This block was
reversed by PI-PLC treatment thus demonstrating that
the tethered toxin was responsible for this inhibition
(PI-PLC: 243.6±31.5pApF−1, n=12) (Fig.3C and D).
We observed a non-statistically signiﬁcant inhibition
(31±13%; Wt: 129.6±22.1pApF−1, Tg-t-MrVIa:
89.3±16.6pApF−1, P =0.23) of TTX-S currents in
nociceptors with a very large sample size (n=32
nociceptors recorded) (Fig.3C). In addition the recovery
of TTX-S currents after PI-PLC enzymatic cleavage of
the tether was not statistically signiﬁcant as it was for
TTX-R currents. Thus the changes in TTX-S currents
observed in transgenic mice might be indicative of partial
(but not statistically signiﬁcant) antagonistic activity of
the t-MrVIa on these channels (Fig.3C). Furthermore,
we used a pulse protocol that avoids any substantial
contamination by Nav1.9, which undergoes ultraslow
inactivation such that clamping the membrane potential
for several minutes to at least −100mV is required to
release it from inactivation (Cummins et al. 1999; Amaya
et al. 2006). Given that we used a holding potential of
−60mV while measuring TTX-R currents, similar to the
experiments performed with the soluble toxin (Daly et al.
2004), our results demonstrate a block of Nav1.8 TTX-R
channels by t-MrVIa in vivo.
We next tested the effect of t-MrVIa on isolectin-B4
positive (IB4+ve) nociceptors, which have a higher
density of TTX-R currents (Dib-Hajj et al. 1998; Stucky
& Lewin, 1999; Snape et al. 2010). Voltage clamp
analyses in DRG neurones live-labelled with ﬂuorescently
coupled IB4 indicated that the t-MrVIa-mediated
block was 48±8% in the IB4+ve neurone population
(Wt: 422.7±57.0pApF−1, n=10, Tg-t-MrVIa:
221.8±33.2pApF−1, n=12) and 48±9% in the
IB4–ve population (Wt: 215.1±33.6pApF−1, n=20;
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Figure 3. t-MrVIa acts at the cell membrane and speciﬁcally blocks TTX-R currents with no compensatory
upregulation of other VGSCs
A, t-MrVIa (FLAG: red) colocalizes with the membrane marker WGA (blue) in DRG neurones co-electroporated with
t-MrVIa and cytoplasmic EGFP (upper panel). PI-PLC treatment eliminates FLAG immunoreactivity showing speciﬁc
cleavage of the GPI-anchored toxin from the membrane (lower panel). Scale bars: 5 μm. B, mammalian cells
transfected with t-MrVIa show expression of the toxin in the membrane fraction by FLAG immunoprecipitation.
C, bar graph indicating the quantiﬁcation of VGSC peak currents in nociceptors of wild-type (Wt) and Tg-t-MrVIa
mice (n = 32 cells per group) before and after TTX and PI-PLC treatment (n = 12 cells). The current densities of
total VGSC and TTX-R currents are signiﬁcantly reduced in Tg-t-MrVIa mice compared to wild-type mice, and
signiﬁcantly recover from t-toxin inhibition after PI-PLC treatment. TTX-S currents are not signiﬁcantly affected
in Tg-t-MrVIa mice. D, current–voltage relationships of TTX-R currents indicate a signiﬁcant inhibition of sodium
currents in nociceptors of Tg-t-MrVIa mice in comparison to Wt littermates (P < 0.05 two-way-ANOVA), and no
signiﬁcant inhibition, with respect to Wt, in Tg-t-MrVIa mice after PI-PLC treatment (P > 0.05 two-way ANOVA).
E, peak current measurements in nociceptors treated with TTX and live-labelled with isolectin B4 indicate that
IB4+ve nociceptors display more TTX-R than IB4–ve nociceptors in Wt and Tg mice and that t-MrVIa inhibition
is signiﬁcant in both subpopulations but more pronounced in IB4+ve nociceptors (n = 10–22 cells per group).
F, the mean amplitude of action potentials is signiﬁcantly reduced in IB4+ve nociceptors (Wt: 89.2 ± 2.3 mV,
Tg-t-MrVIa: 74.3 ± 3.9 mV) but not in IB4–ve nociceptors and mechanoreceptors (t test). (n = 9–20 per group.)
G, immunodetection of substance P (red) and isolectin B4 (green) in dorsal spinal cord indicate no differences in
afferent innervation between Wt and Tg-t-MrVIa adult mice. Scale bar: 50 μm, t test in C and E.
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Tg-t-MrVIa: 111.6±19.2pApF−1, n=19) (Fig.3E;
Supplemental Table2). TTX-R peak current densities
were indeed higher in IB4+ve neurones (Fig.3E)
consistent with the reported higher content of Nav1.8
in this cell population (Stucky & Lewin, 1999; Snape
et al. 2010). We hypothesized that the t-toxin might
have a stronger effect on IB4+ve nociceptors since the
Scn10a gene promoter was used to genetically drive
expression of the t-toxin. Therefore, we measured AP
amplitudes in IB4+ve and IB4–ve nociceptors (Fig.3F).
CurrentclampassaysrevealedthatIB4+vebutnotIB4–ve
nociceptors from Tg-t-MrVIa mice had signiﬁcantly
reduced AP amplitudes ( =14.9mV) (Fig.3F;
Supplemental Table2). No signiﬁcant changes in the
number of myelinated or unmyelinated ﬁbres (A-ﬁbres:
Wt 711.8±3.1, Tg-t-MrVIa 714.8±50.7; C-ﬁbres: Wt
2920.6±197.0, Tg-t-MrVIa 2660.7±173.1; n=3m i c e ;
online Supplemental Fig.3), and in the distribution of
IB4+ve and IB4–ve nociceptor populations (n=2m i c e ,
online Supplemental Fig.4) were observed. The central
terminations in the outer laminae of the dorsal horn
were also unchanged (Fig.3G). In summary, t-MrVIa
selectively reduces TTX-R VGSC currents in nociceptors
in the absence of detectable morphological changes.
A battery of behavioural tests was performed
on Tg-t-MrVIa mice. Motor activity and baseline
sensitivities to noxious thermal and mechanical stimuli,
as well as thermal hyperalgesia after inﬂammation,
were normal (Supplemental Fig.5; Fig.4A). In contrast,
mechanical hyperalgesia after inﬂammation, shown as
the relative threshold for paw withdrawal before and
after inﬂammation, was signiﬁcantly reduced in Tg
mice with respect to wild-type mice (n=10 mice)
(Fig.4B), as was the nocifensive response to noxious
cold (number of licks and jumps during 90s on a
0◦Cp l a t e :W t3 . 3 ±0.9, Tg-t-MrVIa 1.2±0.4) (n=10
mice) (Fig.4C; Supplemental Movies 1 and 2). No
differencesinbehaviouralthermoreceptionwereobserved
(Fig.4D). Thus, our data demonstrate that Tg-t-MrVIa
mice have strong and speciﬁc deﬁcits in nociception. We
next asked whether the behavioural deﬁcits we observed
can be explained by changes in the stimulus–response
properties of identiﬁed cutaneous nociceptors. We thus
used the skin–nerve preparation to measure the ﬁring
frequencies of single cold-sensitive C-ﬁbres. Two types
of cold-activated ﬁbres were recorded when subjected
to a cooling gradient. A low-threshold population
that started ﬁring at innocuous temperatures (∼25◦C,
Fig.4E) and a high-threshold population that started
to respond only below 10◦C( F i g .4 F). While the ﬁring
frequency in the low-threshold population did not differ
between wild-type and Tg-t-MrVIa mice (Fig.4E), the
high-threshold population had signiﬁcantly decreased
ﬁring rates during the cold ramp (Fig.4F). Maximal
differences were observed around 0◦Ci na g r e e m e n tw i t h
our observations on noxious cold-evoked behavioural
responses. The ﬁring rates of C-ﬁbres to noxious
cold were signiﬁcantly different in Tg-t-MrVIa mice,
and were 4.5±1.2spikess−1 (n=8) in wild-type and
1.9±0.5spikess−1 (n=4) in Tg-t-MrVIa mice when
the cold ramp reached 0◦C( F i g . 4 F). Thus our data
indicate that TTX-R VGSC currents blocked by t-MrVIa
in nociceptors are required both for nociception in the
cold and for detection of noxious cold per se.
Discussion
This study establishes the utility of genetically encoded,
cell membrane-anchored peptide toxins to dissect the
contribution of VGSC conductances in a deﬁned neuro-
nal type in vivo, and thereby establish a causal link
between cellular physiology and behaviour. We show that
VGSC currents in nociceptors are cell-autonomously and
selectively inactivated by t-MrVIa toxin and that this
block can be reversed by enzymatic cleavage of the tether
(Fig.3). Within the targeted neuronal population, the
t-toxinshowsahighdegreeofspeciﬁcityforTTX-RVGSCs
andtherewasnoevidenceforcompensatorychangesinthe
activityofotherionchannelspresentinthesameneurones
such as TTX-S VGSCs, VGCCs and TRP channels.
Detailed studies of Nav1.8 and Nav1.7 ion channel
mutations have demonstrated the distinct roles of these
channels in vivo, and compensatory mechanisms that
are activated in abnormal physiological states (Akopian
et al. 1999; Nassar et al. 2004; Rush et al. 2006). For
example, analyses of Nav1.8 knockout mice have shown
that functional inactivation of Nav1.8 is accompanied
by a signiﬁcant upregulation (about twofold) of TTX-S
currents and a compensatory shift of the steady-state
inactivation due to over-expression of Scn9a transcripts
encoding the TTX-S VGSC Nav1.7 (Akopian et al.
1999; Matsutomi et al. 2006). Here we asked whether a
similarcompensatorymechanismoperatesinTg-t-MrVIa
mice. As described above, partial inhibition of TTX-R
currents in Tg-t-MrVIa was observed with no evidence
of compensation by TTX-S currents. Interestingly the
selective, but partial, block of TTX-R currents in the
Tg-t-MrVIa mice described here resulted in pain-related
phenotypes such as reduced mechanical hyperalgesia and
insensitivity to noxious cold, which have been previously
observedinNav1.8nullmutantmiceandininvivomodels
with selective inactivation of Nav1.8 (Akopian et al. 1999;
Jarvis et al. 2007; Zimmermann et al. 2007). However,
while cutaneous ﬁbres of Nav1.8 null mutants show a
signiﬁcantreductionofmenthol-sensitizedcoldresponses
(Zimmermann et al., their Fig.3G) and reduced ﬁring
rates when stimulated by constant mechanical pressure at
low temperatures (Zimmermann et al., their Fig.3E and
F)theydonotshowdifferencesincold-induceddischarge
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activity (Zimmermann et al., their Fig.S6A). In our study
we show that cutaneous ﬁbres of Tg-t-MrVIa mice have
signiﬁcantly reduced ﬁring rates after stimulation with
cold ramps (from 25◦Ct o0 ◦C) without the concurrent
application of menthol, indicating that TTX-R VGSC
currents sustain the ability of neurones to ﬁre APs at
very low temperatures. Thus the presence of TTX-R
VGSC current is not only responsible for the detection of
mechanical stimuli in the cold, but also for the detection
of noxious cold per se. The apparent discrepancy between
our study and that of Zimmermann and colleagues
might be attributed to the differences in the protocols
used to measure cold-induced responses (a cooling ramp
from 30◦Ct o1 0 ◦C was used by Zimmermann et al.,
Figure 4. Tg-t-MrVIa adult mice show reduced inﬂammatory hyperalgesia and insensitivity to cold pain
A, no differences in inﬂammatory thermal hyperalgesia induced by intraplantar injection of carrageenan were
observed between wild-type (Wt) and Tg-t-MrVIa mice (n = 10 mice). B, induced inﬂammation causes mechanical
hyperalgesia in Wt mice (peak at 4 h) and signiﬁcantly reduced hyperalgesia in Tg-t-MrVIa (n = 10 mice). Dashed
line indicates baseline pain response. C, nocifensive cold responses scored during 90 s on a 0◦C-cooled plate
showed signiﬁcantly reduced responses to noxious cold in Tg-t-MrVIa mice (n = 10 mice). D, temperature pre-
ference tests quantifying the time mice spent in either of two plates kept at 30◦C and 10◦C( n = 8m i c e ) .E,
histogram indicating the ﬁring frequency of cold-sensitive C-ﬁbres with a threshold >10◦C over a cooling gradient
from 30 to 0◦C. The ﬁring frequency did not differ between Wt and Tg-t-MrVIa mice (ﬁbres: n = 8–12 ﬁbres per
group). F, histogram indicating the ﬁring frequency of cold-sensitive C-ﬁbres with a threshold < 10◦C responding
to noxious cold stimuli over a cooling gradient from 30 to 0◦C. The ﬁring frequency of cooling units with a
threshold below 10◦C is signiﬁcantly reduced in Tg-t-MrVIa compared to Wt mice (ﬁbres: n = 4–8 ﬁbres per
group). The lower trace corresponds to the cold ramp stimuli used in both cases. P > 0.05 two-way ANOVA in A
and E; P < 0.05 two-way ANOVA in B and F; P < 0.05 t test in C.
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while we used a ramp from 25◦Ct o0 ◦C). Nonetheless
when the cooling gradient reached 10◦Cw ea l r e a d y
observed reduced ﬁring discharges in Tg-t-MrVIa mice
(Fig.4E). Since studies on Nav1.9−/− null mutants have
not indicated any contribution of these channels to cold
sensitivity (Amaya et al. 2006), the t-MrVIa-mediated
block of TTX-R currents resulting in cold insensitivity
is presumably accounted for by blockade of Nav1.8
exclusively. Studies on corneal C-ﬁbres have shown that
many cold-sensitive afferents sustain discharge to thermal
stimulation even when TTX is applied to the preparation
(Brocketal.1998).Itisthusquitepossiblethattheresidual
TTX-insensitive current generated in the cutaneous
endings of cold-sensitive ﬁbres in the skin of trans-
genic mice is sufﬁcient to preserve afferent responses to
mild cooling. Environmental changes to innocuous cold
temperaturesaredetectedbythementholTRPM8receptor
(Bautista et al. 2007). However, when temperatures
become painful Nav1.8 seems to be not only essential to
maintain the excitability of nociceptors (Zimmermann
et al. 2007), but based on our results the activity of Nav1.8
is also required for nociceptors to detect noxious cold
temperatures.
Nociceptor-speciﬁc VGSCs are important therapeutic
targets and major efforts have been made to screen for
speciﬁc molecules to block their function. For instance,
conotoxins are already used as analgesic drugs. The
MrVIa-relatedconotoxinMVIIa(commercialisedasPrialt
or ziconotide) is a speciﬁc antagonist of N-type VGCCs,
and is used to treat patients with extreme neuropathic
pain that is insensitive to opioids (Thompson et al.
2006). In contrast to local application of such analgesic
peptides, delivered intrathecally via infusion pumps to
avoid severe side effects due to diffusion of the toxin
into the CNS, genetic delivery of tethered toxins to
deﬁned cell populations could become a viable alternate
to prevent toxic effects and repetitive treatment. Future
developments in the safety of gene transfer in humans
offers considerable promise for the application of this
novel tethered toxin technology to treat such extreme
pain in humans. Extension of this approach to other
peptidetoxinstogetherwiththeuseofcell-speciﬁcgenetic
methods, may allow for speciﬁc intervention in deﬁned
neuralcircuitsinvivoandthereforepotentialtreatmentof
diseases caused by channelopathies.
Given the importance of VGSC function for AP
propagation, the extensive use of TTX for functional
inactivation of CNS neurones in vivo, and our
demonstration that t-MrVIa can cell-autonomously
inhibit VGSC function without resulting in misregulation
of other ion channels or alterations in membrane
potential, the extension of this methodology to other cell
types and ion channels could provide a valuable new
tool for the dissection of neural circuits. For instance,
in a complementary study we have used other peptide
toxins to block calcium inﬂux through the VGCCs Cav2.1
and Cav2.2 (Auer et al. 2010). Thus, depending on the
speciﬁcity and mode of action of the natural toxin of
choice, this approach can be used for neuronal silencing
byeitherinhibitingVGCCsandblockingneurotransmitter
release (Auer et al. 2010), or, as in this study, inhibiting
VGSCs and reducing cell excitability. Novel peptide toxin
blockers speciﬁc for VGSC types present in the CNS
(Nav1.6 and Nav1.2) have yet to be discovered, but once
such tools become available our strategy could be then
applied to effectively inactivate AP generation in central
neurones. Thus, our study extends the range of available
methodologies that can be used for genetic studies of
neural circuitry (Luo et al. 2008). Furthermore, our
technique represents a validated means to address the
contribution of speciﬁc ion channels and receptors to
neuronal function and behaviour.
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